The S&P 500 Index (SPX) suffered its worst day of the year last Friday, falling more than 2.5%.The index was within striking distance of an all-time high and had gone more than four and a half months without a 2% daily loss.
The S&P 500 remains resilient in 2026 on AI-led earnings strength, but elevated valuations and geopolitical risks warrant caution.
Folks often talk about how momentum in the ETF community continues to grow towards actively managed funds. After all, per Goldman Sachs and Morningstar, almost a third of fund flows in the U.S. went to active ETFs in lieu of passive peers.
Bank of America is warning investors to take profits on U.S. stocks as a growing number of bear market indicators suggest the market may be approaching a peak.
Three of the largest U.S. equity index funds on the market look like clones at first glance.
“The retreat in bond yields has been supportive of the market
Marvell Technology rose in premarket trading on Monday after it was announced it would be joining the S&P 500 index. The stock surged last week after Nvidia's CEO, Jensen Huang, touted Marvell as the "next trillion-dollar company.
A trading expert has warned that the S&P 500 could face a deeper correction after the index broke several key technical support levels, increasing the risk of further downside in the coming weeks.
Although the S&P 500 reached multiple record highs early in the week, its upward momentum was halted on Friday by the stronger-than-expected jobs report, which triggered the index's largest single-day drop since April 2025. This sharp plunge served as the primary driver behind the 2.6% weekly loss, ultimately snapping the index's nine-week winning streak.
Chipmaker Marvell Technology is set to join the benchmark S&P 500 index, S&P Dow Jones Indices said on Friday.
Marvell, Reddit and a mortgage “dark horse” could make the cut during the next quarterly rebalancing of the benchmark index.
Karsan points investors toward diversification and risk-adjusted strategies that, in his view, could potentially deliver 10-15% annual returns regardless of market conditions.